WHAT IS THE PRICE OF VOYDEYA™?
VOYDEYA tablets are currently available in the two dose strengths and in two bottles. The starting dosage for VOYDEYA is 150 mg three times a day orally. Patients may be titrated up to 200 mg three times a day if the patient’s hemoglobin (Hgb) level has not increased by greater than 2 g/dL after 4 weeks of therapy, if the patient required a transfusion during the previous 4 weeks, or to achieve an appropriate Hgb response based on clinical assessment. VOYDEYA must not be administered as monotherapy and should be prescribed as add-on therapy to ravulizumab or eculizumab. Please see the
Wholesale Acquisition Cost (WAC) for VOYDEYA bottles below.
| Strength | NDC | WAC | Package/Form | |
|---|---|---|---|---|
| 150 mg | 50 mg | 25682-046-92 | $4,131.00 | One 90-count bottle of 50 mg tablets |
| 100 mg | One 90-count bottle of 100 mg tablets | |||
| 200 mg | 100 mg | 25682-043-92 | $5,508.00 | Two 90-count bottles of 100 mg tablets |
WHAT IS WHOLESALE ACQUISITION COST?
Wholesale Acquisition Cost (WAC) generally represents the manufacturer’s published catalog or list price paid by a wholesaler. WAC does not represent actual transaction prices, including those paid by patients, and does not include prompt pay or other discounts, rebates, or reductions in price.
Annual treatment cost per patient depends on the patient’s initial dose and clinical response. Actual cost to the patient is dependent on insurance coverage.
WHERE CAN PATIENTS ACCESS ASSISTANCE WITH INSURANCE AND FUNDING OPTIONS?
Your patient can enroll in OneSource™, Alexion’s support program for patients. Every OneSource Case Manager has received advanced education on your patient’s condition, health insurance options, and resources available to your patient. They are here to help answer any questions your patient might have. For more information visit www.alexiononesource.com